Form 4 Filing for BIOLIFE SOLUTIONS INC

This filing details a transaction by Mathew Aby J., EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC, on April 8, 2026. Mr. Mathew disposed of 515 shares of Common Stock. The disposal was to satisfy tax withholding obligations arising from the release of restricted stock units. The transaction price was $19.27 per share. Following this transaction, Mr. Mathew holds 390,167 shares of BIOLIFE SOLUTIONS INC stock. The filing is made on Form 4.